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A B S T R A C T
The aim of this study was to investigate the molecular characteristics of commensal Escherichia coli
producing extended-spectrum b-lactamases and showing ﬂuoroquinolone resistance circulating in a
healthy population in Ibadan, Nigeria. In total, 101 faecal samples from healthy pregnant women on the
day of admission to hospital were collected and plated on eosin–methylene blue agar supplemented
with cefotaxime. Genotyping demonstrated the presence of the blaCTX-M-15 gene in all of the cefotaxime-
resistant isolates (n = 32), and there was circulation of prevalent clones. The aac(60)-Ib-cr, qnrS1, qepA1
and qnrB1 genes were identiﬁed in several strains. A novel plasmid supporting the spread of the blaCTX-M-
15, blaTEM-1 and qnrS1 genes was identiﬁed in these isolates by complete DNA sequencing.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Chemotherapy of
Infection and Cancer. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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In the last decade, a variety of plasmid-mediated extended-
spectrum b-lactamases (ESBLs) and ﬂuoroquinolone resistance
genes have emerged worldwide in Enterobacteriaceae both from
clinical and community settings. The increasing incidence of
community-acquired infection due to ESBL-producing bacteria
represents a great concern [1–8].
Spread of particular Escherichia coli clones and epidemic
plasmid types has been observed in many countries, which
supported the abrupt worldwide spread of particular ESBL
variants. In particular, E. coli sequence type 131 (ST131) is a
globally disseminated, multidrug-resistant clone responsible for a
high proportion of urinary tract and bloodstream infections and is
associated with production of the CTX-M-15 ESBL and resistance to
ﬂuoroquinolones [9]. The blaCTX-M-15 gene in this clone is often
identiﬁed on IncF plasmids but also on other plasmid types
[5,10,11]. IncF is one of the most frequent plasmid families
detected in Enterobacteriaceae. They are usually low-copy-
number plasmids, >100 kb in size and carry more than one
replicon promoting the initiation of replication (FII, FIA and FIB)
[11,12].* Corresponding author. Tel.: +39 06 4990 3128; fax: +39 06 4938 7112.
E-mail address: alessandra.carattoli@iss.it (A. Carattoli).
http://dx.doi.org/10.1016/j.jgar.2014.12.002
2213-7165/ 2015 The Authors. Published by Elsevier Ltd on behalf of International Socie
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Despite the global success of the ST131 E. coli clone, scarce
information is available on the prevalence and types of multidrug-
resistant E. coli clones and plasmids circulating in developing
countries. Recent studies reported CTX-M-type ESBLs in E. coli
clinical isolates from hospitals, the community and healthy food-
producing animals in Nigeria often associated with ﬂuoroquino-
lone resistance [3,4,13]. In E. coli isolates from outpatients from
Southeastern Nigeria, the association of blaCTX-M-1 ESBL genes with
blaTEM, blaOXA-1 and aac(60)-Ib-cr genes were observed [14].
In this study, CTX-M-15-positive commensal E. coli isolated
from healthy pregnant women on the day of admission to hospital
in Ibadan, Nigeria, were analysed.
2. Materials and methods
2.1. Bacterial strains
From September to November 2011, 101 random faecal
samples were collected from healthy pregnant women on the
day of admission to hospital in Ibadan (Nigeria). Samples were
plated on eosin–methylene blue agar containing 8 mg/L cefotax-
ime (Sigma, Steinheim, Germany). Thirty-two samples were
positive for E. coli growing on cefotaxime. One isolate per patient
was selected for further study and was sent to the Istituto
Superiore di Sanita` (Rome, Italy) for phenotypic characterisation
and molecular typing.ty for Chemotherapy of Infection and Cancer. This is an open access article under the
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Escherichia coli strains were tested for antimicrobial suscepti-
bility by the disk diffusion method following European Committee
on Antimicrobial Susceptibility Testing (EUCAST) guidelines
(http://www.eucast.org) for the following drugs: cefotaxime;
ciproﬂoxacin; gentamicin; tetracycline; and chloramphenicol.
2.3. blaCTX-M-15 and plasmid-mediated quinolone resistance (PMQR)
genes
All strains were screened for the following PMQR and b-
lactamase genes using previously published primers and condi-
tions: qnrA; qnrB; qnrS; qnrC; qnrD; aac(60)-Ib-cr; qepA; oqxAB;
blaOXA; blaSHV; blaTEM; blaLAP; blaCTX-M-1g and blaCMY [15–18].
Amplicons were screened for identiﬁcation of the variant gene.
2.4. Bacterial typing
Genetic relatedness was initially determined by enterobacterial
repetitive intergenic consensus (ERIC) PCR. Strains differing by
more than two bands were classiﬁed as different ERIC types;
strains differing by one band were classiﬁed as ERIC subtypes (i.e.
A2), following previously described procedures [19]. Multilocus
sequence typing (MLST) was performed for the major ERIC types as
previously described [20]. Sequence types (STs) were assigned at
the http://mlst.warwick.ac.uk/mlst/dbs/Ecoli website.
2.5. blaCTX-M-15-carrying plasmids
Plasmid content was determined by the PCR-based replicon
typing (PBRT) method using the PBRT kit (Diatheva s.r.l., Fano,
Italy).
Five prototypic plasmids were transferred by transformation in
E. coli TOP10 chemically competent cells (Invitrogen, Milan, Italy).
Plasmid DNA was puriﬁed using a QIAGEN Plasmid Midi Kit
(QIAGEN Inc., Milan, Italy). Transformants were selected on Luria–
Bertani agar plates (Sigma) containing 8 mg/L cefotaxime.
Replicons in the transformants were determined by PBRT.
2.6. Whole plasmid sequencing
The complete DNA sequence of plasmid pPGRT46 was
determined by applying the 454-Genome Sequencer FLXTM
procedure (Roche Diagnostics, Monza, Milan) on a library obtained
using plasmid DNA puriﬁed from the PgR46 strain using a
PureLinkTM HiPure Plasmid Filter Midiprep Kit (Invitrogen).
Contigs with 130-fold coverage were generated by the gsAssem-
bler software v.2.6 (Roche Diagnostics, Monza, Milan). Gene
prediction was performed for the complete plasmid sequence with
Artemis Software v.8 (Sanger Institute). Pairwise alignment was
performed by a BLASTN and BLASTP homology search (http://blast.
ncbi.nlm.nih.gov/Blast.cgi). PCR-based gap closure was performed
to obtain the complete circular plasmid sequence.
The plasmid sequence has been deposited at the NCBI GenBank
under accession no. KM023153.
2.7. Screening for the pPGRT46 plasmid
Two simplex PCR were designed to screen for the presence
of the pPGRT46 plasmid: one PCR targets the FIB-like replicon
(FIB-pKPN3-FW, 50-GAAATCAACAGGGAAGAGCAAGGA-30; and
FIB-pKPN3-RV, 50-GCTGCTCCATCGCCTTACGC-30); and the second
targets a speciﬁc locus identiﬁed on the pPGRT46 plasmid (BCCT-
FW, 50-ATCGACTTCAAGGCGAATAC-30; and BCCT-RV, 50-TGAAA-
GCCTTAGCATGGCG-30).3. Results and discussion
3.1. Escherichia coli producing CTX-M-15 from Nigeria
Thirty-two cefotaxime-resistant E. coli strains were isolated
from 101 faecal samples obtained from pregnant women on the
day of admission to the hospital in the city of Ibadan. All strains
were positive for the blaCTX-M-15 gene; 17 of them were also
positive for blaTEM-1, 12 for blaOXA-1 and 10 for blaCMY-2 (Table 1).
Of the 32 CTX-M-15-positive strains, 26 (81%) also showed
resistance to ciproﬂoxacin, likely due to mutations in the gyrA and
parC genes, which were not further investigated. However, 22 of
these isolates were positive for one or more PMQR genes: aac(60)-
Ib-cr was detected in 17 strains; 7 strains carried qnrS1; 2 strains
carried qnrB1; and 3 strains carried qepA1; one strain carried both
qnrS1 and qnrB1. None of the isolates carried qnrA, qnrC, qnrD or
oqxAB genes.
Nine ERIC patterns were observed in this collection and strains
were classiﬁed in ERIC types A–I. One strain representative of ERIC
types A, B, C and D, respectively, was chosen and typed by MLST
(Table 1). Molecular typing of this collection clearly highlighted the
presence of certain more frequent ERIC types, suggesting that some
E. coli clones were circulating in the community of healthy
pregnant women in Ibadan. However, none of these strains was
related to the ST131 clone.
3.2. Plasmid analysis
High variability of plasmid replicons was observed in these
strains, also including rare plasmid types such as IncI2 and IncX2.
Only three (9%) of the 32 strains were untypeable by the PBRT
method.
Five prototypic strains representative of the major ERIC and
MLST types were chosen for plasmid analysis (underlined strains in
Table 1). The blaCTX-M-15 gene was successfully transferred from all
of them. This gene was located on an IncF plasmid carrying the FIA,
FIB and FII replicons in the PX1 (ST617) strain and on an IncX2
plasmid in the PX53 strain. Differently, the blaCTX-M-15 plasmids
transferred from strains PgR46 (ST10), PX4 (ST3147) and PX42
types were not typeable by the PBRT method.
The complete sequence of one of these untypeable plasmids,
named pPGRT46, identiﬁed in the PgR46 transformant and carrying
the blaCTX-M-15, blaTEM-1 and qnrS1 genes was obtained and compared
with other plasmids in GenBank (Fig. 1). The largest portion of the
pPGRT46 matched with plasmid pCK41, identiﬁed in the Edward-
siella tarda ﬁsh pathogen in South Korea (EMBL accession no.
HQ332785) [21]. Both harbour the same functional replicon, named
FIB-pKPN3, previously identiﬁed in the pKPN3 plasmid in clinical
isolates of Klebsiella pneumoniae [22]. The blaCTX-M-15 gene
environment was similar to that previously described on the
blaCTX-M-15-carrying plasmid pKDO1 (JX42442) identiﬁed in K.
pneumoniae from paediatric patients in the Czech Republic [22] and
consisted of the ISEcp1 inserted into a Tn3 transposase gene tnpA,
strA, strB, sul2 and an In4-type class 1 integron with the dfrA14 gene
cassette, ﬂanked by the uvp1 resolvase gene that is typical of the
class 1 integrons identiﬁed on IncN plasmids, followed by the relict
of the IncN replicase gene interrupted by an IS26 insertion. pPGRT46
carried qnrS1 in the same environment previously described in
plasmid pINF5 (AM234722).
A completely novel region that did not match with any
nucleotide sequence in GenBank was identiﬁed in pPGRT46. In this
region, a putative remnant phage was identiﬁed, associated with a
novel transporter of the betaine/carnitine/choline transporter
(BCCT) family, ﬂanked by the omp gene encoding for a novel
putative outer membrane protein. A PCR screening was devised to
recognise the pPGRT46 plasmid in the other CTX-M-15-producing
Table 1
Characteristics of the Escherichia coli strains analysed in this study.
Strain namea Resistance ERIC (MLST) b-Lactamase and PMQR genesa Replicon typinga pPGRT46a
PX19 CTX, CIP, GEN, TET A blaCTX-M-15, qepA1 FIA, FIB, FII neg.
PX1 CTX, CIP, GEN, TET, CHL A
(ST617)
blaCTX-M-15 FIA, FIB, FII neg.
PX63 CTX, CIP, GEN, TET, CHL A blaCTX-M-15, qepA1, aac(6
0)-Ib-cr FIA, FIB, FII neg.
PX53 CTX, CIP, GEN, TET A blaCTX-M-15, blaTEM-1 qnrS1, aac(6
0)-Ib-cr X2 neg.
PX66 CTX, CIP, GEN, TET, CHL A blaCTX-M-15, qnrS1, qnrB1, aac(6
0)-Ib-cr HI2, Y neg.
PX18 CTX, CIP, GEN, TET, CHL A blaCTX-M-15, blaOXA-1, blaTEM-1 FIA neg.
PX14 CTX, CIP, GEN, TET, CHL A blaCTX-M-15, blaOXA-1, blaCMY-2, blaTEM-1, aac(60)-Ib-cr FIB, FII neg.
PX7 CTX, CIP, GEN, TET, CHL A2 blaCTX-M-15, blaCMY-2, blaTEM-1, qnrS1 FII neg.
PX40 CTX, CIP, GEN, TET B blaCTX-M-15 FIA, FIB, FII neg.
PX55 CTX, CIP, GEN, TET B blaCTX-M-15 FIA, FIB neg.
PX5 CTX, CIP, GEN, TET B blaCTX-M-15, aac(6
0)-Ib-cr FIA, FIB neg.
PgR46 CTX, GEN, TET B
(ST10)
blaCTX-M-15, blaTEM-1, qnrS1, aac(6
0)-Ib-cr Y FIB-pKPN3; BCCT
PgR61 CTX, GEN, TET B blaCTX-M-15, blaTEM-1, qnrS1, aac(60)-Ib-cr FII FIB-pKPN3; BCCT
PX60 CTX, CIP, GEN, TET, CHL B blaCTX-M-15, blaOXA-1, blaTEM-1 FIB, FII neg.
PX61 CTX, CIP, GEN, TET, CHL B blaCTX-M-15, blaOXA-1, blaTEM-1, aac(60)-Ib-cr FII neg.
PX58 CTX, GEN, TET B blaCTX-M-15, blaOXA-1, blaCMY-2, blaTEM-1, aac(60)-Ib-cr N/T neg.
PX64 CTX, GEN, TET B blaCTX-M-15, blaOXA-1, blaCMY-2, blaTEM-1 FIA, FIB neg.
PgR58 CTX, CIP, GEN, TET, CHL B blaCTX-M-15, blaOXA-1, blaCMY-2, blaTEM-1, aac(6
0)-Ib-cr FIA, FIB, FII neg.
PX4 CTX, CIP C
(ST3147)
blaCTX-M-15, qnrS1, blaCMY-2 N/T neg.
PX8 CTX, CIP, GEN, TET, CHL C blaCTX-M-15, blaOXA-1, blaTEM-1, aac(60)-Ib-cr FIA, FIB neg.
PX9 CTX, GEN, TET D blaCTX-M-15, blaTEM-1 FIA, FIB, FII neg.
PX68 CTX, CIP, TET, CHL D
(ST156)
blaCTX-M-15, qepA1 N/T neg.
PX48 CTX, CIP, GEN, TET, CHL D blaCTX-M-15, blaCMY-2, blaOXA-1, blaTEM-1, aac(6
0)-Ib-cr N, FIB FIB-pKPN3; BCCT
PX52 CTX, TET, CHL E blaCTX-M-15, blaOXA-1 blaTEM-1 qnrS1, aac(6
0)-Ib-cr I2 neg.
PgR10 CTX, CIP, GEN, TET, CHL E blaCTX-M-15, blaOXA-1, qnrB1 HI2 neg.
PX49 CTX, CIP, GEN, TET, CHL F blaCTX-M-15, blaOXA-1, blaCMY-2 FIA, FIB, FII neg.
PX10 CTX, CIP, GEN, TET, CHL G blaCTX-M-15, blaTEM-1, aac(60)-Ib-cr HI2, I1 FIB-pKPN3; BCCT
PX51 CTX, CIP, GEN, TET, CHL G blaCTX-M-15, blaCMY-2, aac(60)-Ib-cr FIB, X1, FII neg.
PX42 CTX, CIP, GEN, TET, CHL G blaCTX-M-15, blaTEM-1 FIB, FII, Y FIB-pKPN3; BCCT
PX46 CTX, CIP, GEN, TET, CHL H blaCTX-M-15, aac(6
0)-Ib-cr FIA, FIB, X1 neg.
PX44 CTX, CIP, GEN, TET, CHL I blaCTX-M-15 FIA, FIB, HI2, X1, neg.
PX56 CTX, CIP, TET, CHL I blaCTX-M-15, blaCMY-2, aac(6
0)-Ib-cr FII neg.
N/T, not typeable; neg., negative for the FIB-pKPN3 and BCCT PCRs used as markers for the presence of the pPGRT46 plasmid.
a Prototypic strains selected for transformation experiments and their resistance genes and replicons transferred by transformation are underlined.
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Fig. 1. Major structural features of plasmid pPGRT46 identiﬁed in Escherichia coli PgR46 strain. Coloured boxes represent different functions/loci: white, plasmid scaffold
regions (i.e. the tra locus); yellow, resistance determinants; red, transposon-related genes (tnpA, tnpR, tnpM), class 1 integrase and insertion sequences; blue, blaCTX-M-15;
violet, replicase genes; and green, the novel betaine/carnitine/choline transporter (BCCT) ﬂanked by an omp gene. The black lines indicate the region of the most closely
related plasmids pKDO1 (JX424423), pINF5 (AM234722) and pCK41 (HQ332785), showing 99% nucleotide identity by BLASTN. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of the article.)
D. Fortini et al. / Journal of Global Antimicrobial Resistance 3 (2015) 9–12 11strains from Nigeria. A PCR for the FIB-pKPN3 replicon and a PCR
devised on the gene of the new BCCT transporter identiﬁed
plasmids relative to the pPGRT46 in another four strains of this
collection, belonging to different STs and ERIC types (Table 1).
Further evidence is required to determine whether this putative
phage carrying a novel transporter may have an inﬂuence on
virulence and resistance adaptation of the E. coli recipient host.4. Conclusions
In the present study, ca. 30% of the commensal E. coli strains
obtained from pregnant women in the city of Ibadan, Nigeria, were
cefotaxime-resistant and positive for the blaCTX-M-15 gene. Most
of these strains also showed resistance to ciproﬂoxacin.
Bacterial typing suggested a multifocal distribution of the
D. Fortini et al. / Journal of Global Antimicrobial Resistance 3 (2015) 9–1212CTX-M-15-producing E. coli strains. IncF plasmids have been
involved in the intercontinental spread of CTX-M-15 [11], and in
this study a variety of heterogeneous IncF plasmids were
identiﬁed. A novel IncF plasmid was identiﬁed at the origin of
dissemination of blaCTX-M-15 and qnrS1 in some of these isolates.
The biological characteristics of the colonising strains suggest that
the predominant CTX-M gene is carried by plasmids that are
exchanged between strains.
These results are in agreement with what has been recently
reported by Woerther et al. [8]: it has been estimated that over 110
million ESBL-positive E. coli carriers appear to be present in the
community populations of Africa, and CTX-M enzymes are
practically exclusively of allele 15. Antibiotic use, poor access to
drinking water, poverty, and hygiene failures in the community
and in hospitals, further dramatically increased ESBL-positive E.
coli transmission and dissemination in this continent [8].
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